Scalability in the in vitro diagnostics (IVD) industry is crucial for allowing businesses to grow and adapt to market changes. By offering scalable solutions, Medix Biochemica meets our customers’ evolving needs and helps them to stay competitive in this cutting-edge industry.1
Scalability is the measure of an organization’s ability to provide products or services at an increased pace or on a larger scale without major changes to its infrastructure. A scalable business can increase or decrease its output according to changes in customer demand without compromising quality, efficiency or batch-to-batch consistency.2
Medix Biochemica’s scalability ensures that our customers can start small and then grow their operations as demand grows, realizing the efficiencies and cost savings that come with increased scale.1
Here are the practices Medix Biochemica has put in place to allow for excellent scalability, providing our IVD raw materials in batch sizes ranging from milligrams to kilograms:3
|
Processing tank at St. Louis site utilized for clinical enzymes |
An example of our scalability at work:4 During the COVID-19 pandemic, we quickly and efficiently proved our scalability by meeting the dramatically increased demand for the biospecimens used in our customers’ test kits. In the early days of the pandemic, we received a request to produce a kilogram of an antibody which binds to human IgG. Thanks to our highly scalable cell culture process and production capacity, we were able to meet this requirement. Our large multinational customer reports that Medix Biochemica was the only antibody supplier able to accommodate their request, “and we asked everyone”. |
Contact us to discuss your IVD solution needs
Scalability is important because it has the following key advantages:2
A scalable business can rapidly adapt to changes in the marketplace by increasing or decreasing production. For example, if there's a sudden surge in demand for a specific monoclonal antibody (mAb), Medix Biochemica can quickly increase production to meet this demand without sacrificing our product quality or production efficiency.
A scalable business can quickly add more resources to its infrastructure during periods of high demand, ensuring that customers can always access the products and services they need. Customers benefit from the convenience and flexibility of product scaling, improving customer loyalty. Being scalable also means the business avoids wasting resources on unused capacity.
Successful scaling means a company can increase or decrease production without incurring significant extra costs.
Because Medix Biochemica is a scalable company, we can leverage our robust manufacturing processes and flexible production capabilities to provide IVD raw materials that meet the growing demands of our customers.1
We take the necessary steps to ensure a strong and reliable supply chain, staying agile and offering the ability to scale up quickly to meet any increase in demand. Open customer communication and forecasting play a big role in this capability.4
The scientific professionals at Medix Biochemica have decades of experience in the development of essential raw materials for diagnostic applications. With one in five employees dedicated to the design and development of new products, we’re able to keep up with all aspects of the IVD industry and scale our offerings quickly and efficiently. Our customer-centric approach makes us the ideal partner to meet your needs.5
Scalability enhances supply security and alleviates the challenges associated with revalidating after switching vendors or developing new processes. At Medix Biochemica, we have numerous unit operations and the years of expertise needed to develop, optimize and scale up just about any protein required by our customers.1
Discuss your bespoke requirements with us: our experienced R&D and analytical teams will tailor or scale up processes to deliver the right product and solutions for your final application.5
References: